Getein Biotech

Getein Biotech Dividend

The Dividend of Getein Biotech (603387.SS) as of Nov 5, 2026 is 0.18 CNY. In the previous year, Dividend was 0.19 CNY — a change of -5.26% (lower).

Dividend

0.18CNY

YoY

-5.26%

Dividend yield

2.09 %

Last updated:

How much dividend does Getein Biotech 2026 pay?

According to the latest status from November 2026, Getein Biotech paid a total of 0.18 CNY per share in dividends within the last 12 months. With the current Getein Biotech price of 8.60 CNY, this corresponds to a dividend yield of 2.13 %. A dividend is paid times per year.

Getein Biotech currently offers a dividend yield of about 2.09%. The payout ratio is around 38% of earnings. The dividend has grown at 6.3% per year over the past 7 years.

Historical Getein Biotech Dividends

A dividend is paid times per year. Last year, the payout months were July and October.

Historical Getein Biotech Dividends
PaydateDividend
0.15CNY
0.09CNY
0.09CNY
0.09CNY
0.10CNY
0.10CNY
0.30CNY
0.34CNY
0.18CNY
0.20CNY
0.15CNY
0.12CNY

The Getein Biotech Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2018
0.12 CNY
Jan 1, 2019
0.15 CNY
Jan 1, 2020
0.20 CNY
Jan 1, 2021
0.18 CNY
Jan 1, 2022
0.34 CNY
Jan 1, 2023
0.40 CNY
Jan 1, 2024
0.19 CNY
Jan 1, 2025
0.18 CNY
The Getein Biotech Dividend history
YEARDividendYoY
0.18CNY-5.26%
0.19CNY-52.50%
0.40CNY+17.65%
0.34CNY+85.08%
0.18CNY-10.00%
0.20CNY+36.61%
0.15CNY+27.58%
0.12CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

Getein Biotech dividend history and estimates

In 2025, Getein Biotech paid a dividend amounting to 0.18 CNY. Dividend means that Getein Biotech distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.12 CNY
0.00 CNY
Jan 1, 2019
0.15 CNY
0.00 CNY
Jan 1, 2020
0.20 CNY
0.00 CNY
Jan 1, 2021
0.18 CNY
0.00 CNY
Jan 1, 2022
0.34 CNY
0.00 CNY
Jan 1, 2023
0.40 CNY
0.00 CNY
Jan 1, 2024
0.19 CNY
0.00 CNY
Jan 1, 2025
0.18 CNY
0.00 CNY

Is the Getein Biotech Dividend Safe?

Getein Biotech has been increasing the dividend for 0 years.

Over a five-year period, the distribution dropped by -2.48%.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Getein Biotech dividend payout ratio

In 2025, Getein Biotech had a payout ratio of 38.24%. The payout ratio indicates the percentage of the company's profits that Getein Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
24.60 %
Jan 1, 2019
22.62 %
Jan 1, 2020
33.38 %
Jan 1, 2021
24.28 %
Jan 1, 2022
34.31 %
Jan 1, 2023
72.57 %
Jan 1, 2024
43.83 %
Jan 1, 2025
38.24 %

Dividend Details

Understanding Getein Biotech's Dividend Distributions

Getein Biotech’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Getein Biotech's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Getein Biotech's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Getein Biotech’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Getein Biotech Stock analysis

What does Getein Biotech do? Getein Biotech Inc generates revenue through the sale of in vitro diagnostic reagents and diagnostic instruments. The company offers POCT reagents, chemiluminescence reagents, biochemical reagents, blood cell reagents, and hemagglutination reagents. Diagnostic instruments include the FIA 8000 and FIA 8600 immunoquantitative analyzers, Getein 1100 and Getein 1180 fluorescence immunoquantitative analyzers, CM 400 automatic biochemical analyzer, MAGICL 6000 automatic chemiluminescence analyzer, and BHA-5000 five classification blood cell analyzer. The firm also provides testing and agency services. Products are distributed domestically and to overseas markets. The primary buyers of Getein Biotech's products include healthcare facilities, laboratories, and medical institutions within China and international markets. Domestic sales focus on the Chinese healthcare sector, while overseas markets extend to global customers seeking diagnostic solutions. The company's reagent and instrument portfolio targets hospitals, clinics, and diagnostic centers requiring reliable testing equipment and consumables. Getein Biotech's revenue streams are derived from direct sales of its diagnostic reagents and instruments, as well as service-based offerings like testing and agency services. The company's product range caters to both domestic and international healthcare providers, with a strong emphasis on in vitro diagnostic solutions for blood analysis, chemiluminescence, and biochemical testing. The firm's distribution strategy ensures its products reach medical facilities across China and internationally. Getein Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Getein Biotech stock

Over the past 12 months, Getein Biotech paid a dividend of 0.18 CNY . This corresponds to a dividend yield of about 2.09 %. For the coming 12 months, Getein Biotech is expected to pay a dividend of 0.18 CNY.

The current dividend yield of Getein Biotech is 2.09 %.

Getein Biotech pays a dividend, distributed in the months of September, June.

Getein Biotech paid dividends every year for the past 8 years.

For the upcoming 12 months, dividends amounting to 0.18 CNY are expected. This corresponds to a dividend yield of 2.13 %.

Getein Biotech is assigned to the 'Health' sector.

In the year 2025, Getein Biotech distributed 0.18 CNY as dividends.

The dividends of Getein Biotech are distributed in CNY.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Getein Biotech